Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Celestica Inc (CLS) vs Xylem, Inc. (XYL) Price & Performance

Celestica IncTrade
Xylem, Inc.Trade

Price performance (Past 24H)

Key statistics

Celestica Inc vs Xylem, Inc. — how do they compare? Celestica Inc trades at $333.51 (market cap $39.16B), while Xylem, Inc. trades at $120.98 (market cap $28.76B). The key difference: Celestica Inc is the larger of the two by market cap, and Xylem, Inc. pays a 1.4% dividend while Celestica Inc pays none. Which is the better fit depends on your goals.

CLSXYL
Market Cap
$39.16B$28.76B
Sector
TechnologyIndustrials
52-Week High
$472.40$152.95
52-Week Low
$181.34$106.34
Enterprise Value
$39.44B$30.54B
Dividend Yield
1.4%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Celestica Inc

CLS trades at $327.15, up 3.99% in 24 hours, with a bearish technical signal but strong fundamentals including a 52.69% ROE and Q2 2026 EPS of $2.54 beating estimates. Recent news highlights a $3 billion equity offering to fund AI infrastructure growth, though this may cause near-term dilution.

The outlook is positive with analyst consensus at Buy (64.29%) and a $466.50 price target, driven by AI demand and partnerships. Risks include equity dilution and premium valuation, but growth catalysts from hyperscaler investments support long-term upside.

Xylem, Inc.

Xylem (XYL) trades at $121.19, up 0.72% today, with a bullish technical trend and strong fundamental performance. The company reported Q2 2026 EPS of $1.46, beating estimates, and raised full-year profit guidance. Revenue growth is steady, with a net income margin of 11.15% in 2025. Recent acquisitions, like Cornell Pump and Roper Pump, aim to strengthen its industrial water technology presence. The stock shows bullish moving averages but a neutral RSI, with key resistance at $123.

Outlook remains positive due to earnings beats, margin expansion, and strategic acquisitions. Risks include execution of integration and macroeconomic pressures. Analyst consensus is a buy with a $150.43 price target, implying significant upside. Institutional activity is mixed, with some funds increasing stakes while others reduced holdings.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Celestica Inc

Celestica provides supply chain and manufacturing solutions for global technology companies. It specializes in high-complexity assembly and platform solutions for AI data centers, aerospace, and medical markets.

Read more on CLS

About Xylem, Inc.

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.

Read more on XYL